Probity Advisors Inc. bought a new position in BioNTech in the 3rd quarter worth $216,000. Finally, Blue Trust Inc. boosted its stake in shares of BioNTech by 491.1% during the 3rd quarter.

the result of a bid to strike it down filed by BioNTech. The invalidation has come out of the blue for CureVac, which said earlier in the year that the patent court had supported its position in ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

By disparaging public-health methods and discrediting vaccines, the COVID‑19 minimizers cost hundreds of thousands of people ...

The global biotechnology market was worth USD 1.68 trillion in 2024 and is expected to surge around USD 3.54 Trillion by 2033, with a noteworthy CAGR of 9.18% from 2024 to 2033. The growing demand for ...

But Pfizer’s almost Hollywood-level blockbuster of the 1990s was the little blue pill of Viagrar ... approved – via its collaboration with BioNTech – it feels like we're only on the cusp ...

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

Alphabet's Google launched an experimental version of its search engine on Wednesday that completely eliminates its classic ...

EXCLUSIVE: Great news for Blue Bloods fans — one of the beloved drama’s signature characters, Donnie Wahlberg’s Danny Reagan, will be back on CBS with a new ‘Blue’ cop show in a new city.